Skip to contentV
Vivani Medical, Inc.
V
VANIVivani Medical, Inc. Q2 2026 · 10-Q
Revenue—
Net Income-$6.37M-$6.37MN/M vs Q2 2025 EPS Diluted-$0.07-$0.07N/M vs Q2 2025 Operating Income-$6,874,000N/M Operating Cash Flowderived-$6,035,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vivani Medical, Inc. · CIK 1266806 · Engraved from SEC EDGAR
Free Cash Flowderived-$6,134,000N/M ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end